04 July 2024
Top global hires for large-cap, mid-cap and public companies H1-2024
Recent top global hires for large-cap, mid-cap, and public companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
CEO/ C-suite/ Board
| Function | Focus area | Location |
|---|---|---|
| CEO | Medical equipment (publicly listed) | US/ UK |
| Chief Development Officer | Biotech (publicly listed) | Europe |
| Chief R&D Officer | Mental healthcare (publicly listed) | US |
| Chief Technology Officer | AI-enabled drug discovery (publicly listed) | Europe |
| Chief, Operations & Supply Chain | Speciality pharma (mid-cap) | Europe |
| Board Director | Biopharma (publicly listed) | US |
| Board Director | Novel enzymes (publicly listed) | Nordics |
| Group General Counsel | Animal health (large-cap) | Europe |
Commercial / Functional / Strategic Leadership
| Function | Focus area | Location |
|---|---|---|
| VP Business Development | Biotech (publicly listed) | US/Canada |
| VP Sustainability | Generics (publicly listed) | UK |
| VP Commercial Excellence | Pharma (mid-cap) | Europe |
| VP Global Total Reward | Generics (mid-cap) | UK |
| VP Legal | Biopharma (publicly listed) | US |
| Country Manager | Drug discovery (mid-cap) | Europe |
| Country Value & Access Lead | Speciality pharma (mid-cap) | Europe |
| Country Franchise Lead, Metabolic Diseases | Drug discovery (large-cap) | Europe |
| Business Development and Marketing Director | Diagnostic services (large-cap) | Europe |
| Commercial Excellence Director | Medical devices (mid-cap) | Europe |
R&D/ Medical/ Technical
| Function | Focus area | Location |
|---|---|---|
| VP Translational Neuroscience | Biotech (large-cap) | US |
| VP R&D | Specialty pharma (large-cap) | Europe |
| VP Artificial Intelligence & Informatics | Computational biotech (publicly listed) | UK |
| VP Pharmacovigilance | Biopharma (publicly listed) | Europe |
| VP Regulatory | Pharma (mid-cap) | US/ Europe |
| Head of Medicinal Chemistry | Drug Discovery (publicly listed) | Nordics |
| Head of Global Technical Operations | Biopharma (mid-cap) | Europe |
| Head of PK/PD and Toxicology | Specialty pharma (large-cap) | Europe |
| Executive Director, Non-Rx R&D | Specialty Pharma (mid-cap) | Europe |
| Regional Medical Affairs Lead | Pharma (mid-cap) | Nordics |
Related
-
Events
AESC Global Summit on Leadership
17 November 2025 – 18 November 2025
-
Company News
LSX World Congress conference with Justine McIlroy, Client Partner
12 May 2023
-
Thought Leadership
Five Shifts to Digital Personalized Healthcare
10 May 2023
-
Company News
Digital Health UK CEO and Commercial Leaders Breakfast
28 March 2023